Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Multiple Ascending Doses (MAD) of Anti-A Disintegrin and Metalloproteinase With Thrombospondin Motifs-5 (Anti-ADAMTS-5) Nanobody in Participants With Knee Osteoarthritis (OA)

Merck KGaA, Darmstadt, Germany · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
kneeosteoarthritis
osteoarthritis, knee, m6495, anti-adamts-5 nanobody, osteoarthritis, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 897767
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.